PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA; NewYork-Presbyterian Hospital/Weill Cornell Medical Campus, New York, NY, USA.\', \'ET HealthCare, Palo Alto, CA, USA.\', \'NewYork-Presbyterian Hospital/Weill Cornell Medical Campus, New York, NY, USA.\', \'NewYork-Presbyterian Hospital/Weill Cornell Medical Campus, New York, NY, USA; Department of Emergency Medicine, Weill Cornell Medical Center, New York, NY, USA.\', \'Diagnostic Immunology Laboratory, Wadsworth Center, New York State Department of Health, Albany, NY, USA.\', \'Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA.\', \'Department of Microbiology and Immunology, Weill Cornell Medicine, New York, NY, USA.\', \'Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.\', \'Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA; NewYork-Presbyterian Hospital/Weill Cornell Medical Campus, New York, NY, USA. Electronic address: zhz9010@med.cornell.edu.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0956-5663(21)00044-010.1016/j.bios.2021.113008
?:hasPublicationType
?:journal
  • Biosensors & bioelectronics
is ?:pmid of
?:pmid
?:pmid
  • 33515984
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Testing-on-a-probe biosensors reveal association of early SARS-CoV-2 total antibodies and surrogate neutralizing antibodies with mortality in COVID-19 patients.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all